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Abstract
Whilst resting disturbances of both diastolic and long-axis systolic function are observed in patients
with heart failure who have normal left ventricular ejection fraction, recent evidence suggests that
dynamic disturbances in cardiac function occur during exercise. A paradoxical slowing of left
ventricular active relaxation during exercise limits cardiac filling and therefore stroke volume and
appears to be due to the combination of cardiac energetic impairment and disturbed ventricular-
vascular coupling.
Introduction and context
Many consider heart failure with preserved ejection
fraction (HFpEF) to be a disorder of diastolic function
(hence the term ‘diastolic heart failure’) [1], whilst others
believe that it may be due to a combination of diastolic
abnormalities with subtle disturbances of systolic func-
tion that are insufficient to reduce left ventricular
ejection fraction (LVEF) [2]. In this review, HFpEF refers
to heart failure patients with an LVEF of greater than 50%
[3,4].
Resting left ventricular stiffness in HFpEF
Diastolic function is influenced by passive elastic proper-
ties of the left ventricle, by the highly energy-dependent
process of active relaxation, and by the atrial contribu-
tion to filling. Zile et al. [5] demonstrated that patients
with HFpEF had abnormal left ventricular (LV) relaxa-
tion and increased resting LV stiffness with a shift in the
diastolic pressure-volume relationship upwards and to
the left. However, other studies have shown that resting
ventricular stiffness is not invariably increased in patients
with HFpEF [6]. Increased myocardial mass or changes in
the extra-myocardial collagen network [1] (increased
collagen content and increased collagen cross-linking)
may contribute to increased LV passive diastolic stiffness
at rest [5]. A study by van Heerebeek et al. [7] examined
differences in titin isoform expression between patients
with systolic and ‘diastolic heart failure’. Titin is a large
cytoskeletal protein that contributes to resting stiffness of
the myocardium [8]. A shift toward the stiffer N2B
isoform was observed in the diastolic heart failure group
and toward the longer N2BA isoform in the systolic heart
failure group when compared with previously published
results from healthy controls [7]. A shift to expression of
the shorter N2B isoform in response to increased arterial
stiffness would increase ‘contractility’ (to compensate for
increased aortic impedance) at the price of increased LV
systolic and diastolic stiffness. More recently, myocardial
biopsies from patients with aortic stenosis and patients
with heart failure suggest that, rather than just a shift in
titin isoforms, other mechanisms such as relative
hypophosphorylation of the stiffer N2B titin isoform
were a possible cause of increased LV stiffness in failing
myocardium [9].
Resting large-artery stiffness and
ventricular-vascular coupling
The interaction between the heart and the systemic
vasculature, termed ventricular-vascular coupling (VVC),
is essential for the heart to achieve maximal cardiac work,
power and chamber efficiency while maintaining phy-
siological blood pressures and cardiac outputs [10]. VVC
is the ratio of arterial elastance (Ea) to end-systolic
elastance (Ees). LV end-systolic elastance (stiffness) (Ees)
is calculated from the slope of the end-systolic pressure-
volume relationship. Arterial elastance (stiffness) (Ea)i s
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of systolic pressure to stroke volume.
Ventricular-vascular interaction is important in the
context of HFpEF because of its important effects on
diastolic filling [11]. In patients with HFpEF, the resting
VVC is lower than in younger individuals [12] but similar
to asymptomatic hypertensive elderly patients [13] and
falls within a range in which cardiac work and efficiency
are not compromised [14]. However, although the
resting VVC ratio is within the physiological range, the
absolute values of Ees and Ea are considerably elevated,
indicating increased arterial and ventricular systolic
stiffness and this becomes important during exercise
(see below).
Systolic, diastolic and vascular function during exercise
In young healthy subjects, exercise is associated with an
increase in contractility and in the rate of LV active
relaxation, although the latter is attenuated with
increasing age [15]. In HFpEF, these physiological
changes during exercise are profoundly deranged and
this appears to be central to the pathophysiology of the
disorder. In a small study by Kitzman et al. [16], HFpEF
patients underwent invasive cardiopulmonary exercise
testing. HFpEF patients exhibited a shift of the LV end-
diastolic pressure-volume relationship upward and to
the left at rest, and during exercise increases in LV filling
pressure were not accompanied by increases in end-
diastolic volume index, indicating a limitation to LV
filling during exercise and a failure of the Frank-Starling
mechanism [16]. More recently, a study conducted by
Kawaguchi et al. [6] reported a dynamic impairment of
LV active relaxation during isometric (handgrip) exercise
in a group of HFpEF patients.
These findings suggest a potentially attractive link
between increased large-artery stiffness and exercise-
induced diastolic dysfunction. Animal studies have
demonstrated that a large acute increase in afterload in
healthy hearts of rabbits resulted in a marked slowing of
active relaxation and impaired LV diastolic filling [17].
However, acute increase in afterload required to cause a
slowing of active relaxation may be much less in a
diseased heart compared with a healthy heart. The
concept of ‘relative load’, which represents the ratio of
systolic LV pressure to isovolumetric LV pressure [18],
allows for the possibility that an increase in afterload
required to cause a slowing of active relaxation may be
much less in a diseased heart compared with a healthy
heart. A similar systolic LV pressure represents a higher
relative load in the failing heart than in the normal heart.
When relative load is low, afterload reserve is still
available, allowing the heart to face increased afterload
without slowing of LV active relaxation. When relative
load is high, afterload mismatch [19] occurs and a
pronounced slowing of LV active relaxation is observed
[18]. Other extra-cardiac factors that may contribute to
the pathophysiology of HFpEF include volume overload
in conditions such as anaemia, renal dysfunction and
obesity [20]. In addition, previous data in an animal
model have indicated that neurohormonal activation
with intravascular volume expansion following relatively
small degrees of ischaemic myocardial injury can lead to
elevated LV end-diastolic pressure in the absence of
diastolic dysfunction or reductions in maximal dP/dt
(rate of rise of LV pressure) or EF [21].
Major recent advances
Borlaug and colleagues [22] recently reported that
hypertensive patients with or without HFpEF had
increased arterial and LV stiffness but similar VVC at
rest. However, despite the apparently ‘preserved’ EF,
patients with HFpEF had depressed cardiac contractility
compared with asymptomatic hypertensive subjects [22].
This was consistent with other studies that had used
tissue Doppler imaging and had demonstrated the
presence of diastolic or systolic dyssynchrony or both
in patients with HFpEF [23,24].
A study by Westermann et al. [25], involving pressure-
volume loop analysis with and without atrial pacing in
70 HFpEF patients and 20 matched controls, found that
enhanced LV stiffness can result in increased end-
diastolic pressure during handgrip exercise. In addition,
during atrial pacing, pacing with HFpEF displayed
decreased stroke volume, but it should be noted that
these patients were resting in a supine position and thus
to artificially increase heart rate by atrial pacing might
not reflect true physiological exercise conditions. At the
very least, these data suggest that LV stiffness can
modulate cardiac function in HFpEF patients. Another
group, also using pressure-volume loop analysis,
demonstrated that in HFpEF patients there was indeed
increased LV passive stiffness and prolonged LV relaxa-
tion at rest and, interestingly, that during atrial pacing,
LV relaxation reserve was limited but the cardiac
contractility was normal. The net result was a blunted
cardiac output during atrial pacing [26]. Increased LV
stiffness in HFpEF patients may reflect not only increased
myocardial mass and changes in extra-myocardial
collagen (e.g., titins) but also LV fibrosis as demonstrated
by Martos and colleagues [27], who found marked
serological evidence of active fibrotic processes in
patients with HFpEF.
Using echocardiographic techniques, our group recently
demonstrated that, at rest, LV torsion and strain patterns
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controls [28] but that during exercise HFpEF patients had
reduced systolic and diastolic function as well as
evidence of delayed LV untwisting and LV suction [29].
In a separate study, using radionuclide ventriculography,
we studied 37 HFpEF patients and 20 control subjects
during cycle exercise and demonstrated that HFpEF
patients had marked disturbances of VVC and of both
systolic and diastolic function which appeared to be
responsible for exercise limitation. LV active relaxation
was paradoxically slowed. Ea fell less and Ees increased
much less during exercise than in age-matched controls,
the latter indicating a failure of contractile reserve [30].
The impaired LV diastolic filling during exercise may be
partly compensated by increased left atrial contribution
during the final stages of diastolic filling [31] until atrial
failure and eventually atrial fibrillation supervene later in
the natural history of the disease.
Akeycouplerofload-dependentLVrelaxationistroponin
I-protein kinase A (TnI-PKA) phosphorylation. This
energy-dependent process of phosphorylation of tropo-
nin I by PKA decreases myofibrillar calcium sensitivity
and increases the rate at which calcium dissociates from
troponin C and this can lead to an increased rate of LV
relaxation by increasing the rate of thin filament
deactivation. Using magnetic resonance spectroscopy,
we recently demonstrated that HFpEF patients had
reduced myocardial energetic reserve at rest (decreased
phosphocreatine/adenosine triphosphate [PCr/ATP]
ratio), and this might explain why these HFpEF patients
are particularly prone to impaired LV active relaxation
during exercise and impaired contractile reserve [30].
The cause for this resting energy deficit may relate to
insulin resistance, to impaired mitochondrial function as
a result of ageing, and to neuro-endocrine activation and
aberrant substrate metabolism. In addition, a recent
study in patients with hypertrophic cardiomyopathy
found that reduced myocardial PCr/ATP correlated with
the presence of fibrotic area in the myocardium of the left
ventricle [32].
Future directions
There are consistent data demonstrating markedly
abnormal diastolic responses to exercise in HFpEF. In
our view, the detection of HFpEF patients cannot rely
solely on resting parameters and we need to consider
some form of exercise testing such as metabolic exercise
testing or exercise radionuclide ventriculography or
echocardiography scans in the future.
Future studies should begin to translate key pathophy-
siological findings in HFpEF to an effective clinical
therapy. An effective therapy for HFpEF patients has yet
to be developed. However, the finding that HFpEF
patients have reduced myocardial energetic status may
provide the rationale to assess the therapeutic value of
‘metabolic agents’ (e.g., perhexiline and trimatazidine)
that increase cardiac energetic status by altering cardiac
substrate use [33]. LV stiffness and fibrosis could be
addressed by drugs such as aldosterone antagonists (e.g.,
eplerenone), which may help to alleviate aldosterone-
induced cardiac fibrosis, which causes increased stiffness,
impaired LV relaxation and impaired LV filling.
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